Mills Clinical Research   Report issue

For profit
Founded: Los Angeles CA United States (2012)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2016
NCT03275701
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Mills Clinical Research

Active Ingredients

Drugs in Other Trials (1)

dolutegravir (tivicay) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1